A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myeloma.

Di WangHaiying FuYimei QueHaitao RuanMenglei XuXiaolu LongQiuxia YuChunhui LiZhe LiSongbai CaiWei ChenCong SunGuang HuShuai WangDonggou HeJianming MeiWen WangChun-Rui Li

Published in: Journal of translational medicine (2023)

The combination of Selinexor and CT103A exerts preliminary synergistic effect, and can be developed as a promising strategy for relapsed/refractory extramedullary myeloma.

Keyphrases

multiple myeloma
computed tomography
image quality
contrast enhanced
acute lymphoblastic leukemia
dual energy
acute myeloid leukemia
magnetic resonance imaging
positron emission tomography
magnetic resonance